Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
TuHURA Biosciences, Inc.
TuHURA Biosciences, Inc.
7 Hills Pharma, LLC
Regeneron Pharmaceuticals
Pfizer
Alpha Tau Medical LTD.
Alpha Tau Medical LTD.
Iovance Biotherapeutics, Inc.
Pfizer
Obsidian Therapeutics, Inc.
Merck Sharp & Dohme LLC
CivaTech Oncology
Immorna Biotherapeutics, Inc.
Klein Buendel, Inc.
Filamon LTD
Pfizer
Bristol-Myers Squibb
Ankyra Therapeutics, Inc
Pfizer
Replimune Inc.
AI Labs Group S.L
Regeneron Pharmaceuticals
Iovance Biotherapeutics, Inc.
Elephas
Novartis
Elephas
OncoNano Medicine, Inc.
Alpha Tau Medical LTD.
Alpha Tau Medical LTD.
Alpha Tau Medical LTD.
Alpha Tau Medical LTD.
Alpha Tau Medical LTD.
Massive Bio, Inc.
Nuvana Healthcare LTD
Novartis
Delfi Diagnostics Inc.
Medicenna Therapeutics, Inc.
Skin Analytics Limited
Verrica Pharmaceuticals Inc.
DEKA Biosciences
HJN Sverige AB/Neko Health
HJN Sverige AB/Neko Health
Regeneron Pharmaceuticals
Tempus AI
Turnstone Biologics, Corp.
Revolution Medicines, Inc.
Bristol-Myers Squibb
Alpha Tau Medical LTD.
Barco NV
Checkpoint Therapeutics, Inc.
Mirai Medical